Clinical Research Facility
Upland, California 91786
We've found
8 trials
at this facility
Type 2 Diabetes Mellitus Clinical Trial
Updated: 3/11/2015
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling,
Phase
III
Updated: 3/11/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/25/2015
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling,
Phase
III
Updated: 2/25/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Polymyalgia Rheumatica Clinical Trial
Updated: 12/31/1969
Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment Resistant Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Spondylitis, Ankylosing Clinical Trial
Updated: 12/17/2013
Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)
Status: Upcoming,
Phase
III
Updated: 12/17/2013
Click here to add this to my saved trials